Our work
Topics
Building 8

Krogerus advises A-klinikkasäätiö on the sale of A-klinikka Oy to Attendo

28 Apr 2026 — Competition & Regulatory | Merg...
Abstract 14

Krogerus advises Stifel on Faron's rights offering

15 Apr 2026 — Capital Markets and Public M&A ...
Eb 2

Krogerus advises MB Funds on its investment in Pharmatory

2 Feb 2026 — Mergers & Acquisitions | Health...
Abstract02

Krogerus advises G Square on its acquisition of a majority stake in Serres

26 Jan 2026 — Competition & Regulatory | Merg...
Eb

Krogerus advises Sentica on its sale of Hohde Group to Terveystalo

23 Dec 2025 — Competition & Regulatory | Empl...
Abstract04

Krogerus advises Bioretec on its rights offering

25 Jun 2025 — Capital Markets and Public M&A ...
Abstract 6

Krogerus advises Carnegie on Faron's capital raise

1 Jul 2024 — Capital Markets and Public M&A ...
Eb

Krogerus advises the shareholders of Labquality on Mérieux Equity Partners' majority acquisition

1 Dec 2023 — Competition & Regulatory | Merg...
Molecules

Krogerus advises Evondos on joining forces with Medido

7 Feb 2023 — Mergers & Acquisitions | Health...
Stairs 5

Krogerus advises Attendo Oy on its acquisition of Kaunialan Sairaala Oy

1 Jun 2022 — Competition & Regulatory | Heal...
Health

Krogerus advises Synexa Life Sciences on its acquisition of Syrinx Bioanalytics

20 May 2022 — Mergers & Acquisitions | Tax | ...
Farmacy 3

Krogerus advises Herantis Pharma on its secondary listing on Nasdaq First North Growth Market Sweden...

18 Dec 2019 — Capital Markets and Public M&A ...